0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Covid-19 Impact on Global BioChips and BioMEMS Market Size, Status and Forecast 2020-2026
Published Date: May 2020
|
Report Code: QYRE-Auto-9X2838
Home | Market Reports | Business & Industrial | Pharmaceuticals & Biotech
Covid 19 Impact on Global BioChips and BioMEMS Market Size Status and Forecast 2020 2026

Covid-19 Impact on Global BioChips and BioMEMS Market Size, Status and Forecast 2020-2026

Code: QYRE-Auto-9X2838
Report
May 2020
Pages:133
QYResearch
Description
Table of Content
Tables & Figures

Market Analysis and Insights: Global BioChips and BioMEMS Market

The global BioChips and BioMEMS market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global BioChips and BioMEMS market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global BioChips and BioMEMS market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global BioChips and BioMEMS market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global BioChips and BioMEMS market.

BioChips and BioMEMS Breakdown Data by Type

  • DNA Chips
  • Lab-on-a-chip
  • Biosensors
  • Drug Delivery Systems
  • Microfluidic Devices
  • Biomems Implants
  • Silicon Structures
  • Microactuators

BioChips and BioMEMS Breakdown Data by Application

  • Hospital
  • Labrary
  • Other

Based on regional and country-level analysis, the BioChips and BioMEMS market has been segmented as follows:

North America

  • United States
  • Canada

Europe

  • Germany
  • France
  • K.
  • Italy
  • Russia
  • Nordic
  • Rest of Europe

Asia-Pacific

  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia-Pacific

Latin America

  • Mexico
  • Brazil
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global BioChips and BioMEMS market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.

The following players are covered in this report:

  • Abbott Laboratories
  • Boston Scientific
  • Perkin Elmer
  • Medtronic
  • Baxter International
  • Teledyne Dalsa
  • Cepheid
  • Bluechiip
  • Lepu Medical Technology
  • Emulate
  • TissUse
  • Hesperos
  • CN Bio Innovations
  • Tara Biosystems
  • Draper Laboratory
  • Mimetas
  • Nortis
  • Micronit Microtechnologies B.V.
  • Kirkstall
  • Cherry Biotech SAS
  • Else Kooi Laboratory

 

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by BioChips and BioMEMS Revenue
1.4 Covid-19 Implications on Market by Type
1.4.1 Global BioChips and BioMEMS Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 DNA Chips
1.4.3 Lab-on-a-chip
1.4.4 Biosensors
1.4.5 Drug Delivery Systems
1.4.6 Microfluidic Devices
1.4.7 Biomems Implants
1.4.8 Silicon Structures
1.4.9 Microactuators
1.5 Market by Application
1.5.1 Global BioChips and BioMEMS Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Labrary
1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): BioChips and BioMEMS Industry Impact
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Covid-19 Implications on Global BioChips and BioMEMS Market Perspective (2015-2026)
2.2 Covid-19 Implications on Global BioChips and BioMEMS Growth Trends by Regions
2.2.1 BioChips and BioMEMS Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 BioChips and BioMEMS Historic Market Share by Regions (2015-2020)
2.2.3 BioChips and BioMEMS Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 BioChips and BioMEMS Market Growth Strategy
2.3.6 Primary Interviews with Key BioChips and BioMEMS Players (Opinion Leaders)
3 Covid-19 Implications on Competition Landscape by Key Players
3.1 Global Top BioChips and BioMEMS Players by Market Size
3.1.1 Global Top BioChips and BioMEMS Players by Revenue (2015-2020)
3.1.2 Global BioChips and BioMEMS Revenue Market Share by Players (2015-2020)
3.1.3 Global BioChips and BioMEMS Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global BioChips and BioMEMS Market Concentration Ratio
3.2.1 Global BioChips and BioMEMS Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by BioChips and BioMEMS Revenue in 2019
3.3 BioChips and BioMEMS Key Players Head office and Area Served
3.4 Key Players BioChips and BioMEMS Product Solution and Service
3.5 Date of Enter into BioChips and BioMEMS Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Covid-19 Implications on Market Size by Type (2015-2026)
4.1 Global BioChips and BioMEMS Historic Market Size by Type (2015-2020)
4.2 Global BioChips and BioMEMS Forecasted Market Size by Type (2021-2026)
5 Covid-19 Implications on Market Size by Application (2015-2026)
5.1 Global BioChips and BioMEMS Market Size by Application (2015-2020)
5.2 Global BioChips and BioMEMS Forecasted Market Size by Application (2021-2026)
6 North America Impact of COVID-19
6.1 North America BioChips and BioMEMS Market Size (2015-2020)
6.2 BioChips and BioMEMS Key Players in North America (2019-2020)
6.3 North America BioChips and BioMEMS Market Size by Type (2015-2020)
6.4 North America BioChips and BioMEMS Market Size by Application (2015-2020)
7 Europe Impact of COVID-19
7.1 Europe BioChips and BioMEMS Market Size (2015-2020)
7.2 BioChips and BioMEMS Key Players in Europe (2019-2020)
7.3 Europe BioChips and BioMEMS Market Size by Type (2015-2020)
7.4 Europe BioChips and BioMEMS Market Size by Application (2015-2020)
8 China Impact of COVID-19
8.1 China BioChips and BioMEMS Market Size (2015-2020)
8.2 BioChips and BioMEMS Key Players in China (2019-2020)
8.3 China BioChips and BioMEMS Market Size by Type (2015-2020)
8.4 China BioChips and BioMEMS Market Size by Application (2015-2020)
9 Japan Impact of COVID-19
9.1 Japan BioChips and BioMEMS Market Size (2015-2020)
9.2 BioChips and BioMEMS Key Players in Japan (2019-2020)
9.3 Japan BioChips and BioMEMS Market Size by Type (2015-2020)
9.4 Japan BioChips and BioMEMS Market Size by Application (2015-2020)
10 Southeast Asia Impact of COVID-19
10.1 Southeast Asia BioChips and BioMEMS Market Size (2015-2020)
10.2 BioChips and BioMEMS Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia BioChips and BioMEMS Market Size by Type (2015-2020)
10.4 Southeast Asia BioChips and BioMEMS Market Size by Application (2015-2020)
11 India Impact of COVID-19
11.1 India BioChips and BioMEMS Market Size (2015-2020)
11.2 BioChips and BioMEMS Key Players in India (2019-2020)
11.3 India BioChips and BioMEMS Market Size by Type (2015-2020)
11.4 India BioChips and BioMEMS Market Size by Application (2015-2020)
12 Central & South America Impact of COVID-19
12.1 Central & South America BioChips and BioMEMS Market Size (2015-2020)
12.2 BioChips and BioMEMS Key Players in Central & South America (2019-2020)
12.3 Central & South America BioChips and BioMEMS Market Size by Type (2015-2020)
12.4 Central & South America BioChips and BioMEMS Market Size by Application (2015-2020)
13Key Players Profiles
13.1 Abbott Laboratories
13.1.1 Abbott Laboratories Company Details
13.1.2 Abbott Laboratories Business Overview and Its Total Revenue
13.1.3 Abbott Laboratories BioChips and BioMEMS Introduction
13.1.4 Abbott Laboratories Revenue in BioChips and BioMEMS Business (2015-2020))
13.1.5 Abbott Laboratories Recent Development and Reaction to COVID-19
13.2 Boston Scientific
13.2.1 Boston Scientific Company Details
13.2.2 Boston Scientific Business Overview and Its Total Revenue
13.2.3 Boston Scientific BioChips and BioMEMS Introduction
13.2.4 Boston Scientific Revenue in BioChips and BioMEMS Business (2015-2020)
13.2.5 Boston Scientific Recent Development and Reaction to COVID-19
13.3 Perkin Elmer
13.3.1 Perkin Elmer Company Details
13.3.2 Perkin Elmer Business Overview and Its Total Revenue
13.3.3 Perkin Elmer BioChips and BioMEMS Introduction
13.3.4 Perkin Elmer Revenue in BioChips and BioMEMS Business (2015-2020)
13.3.5 Perkin Elmer Recent Development and Reaction to COVID-19
13.4 Medtronic
13.4.1 Medtronic Company Details
13.4.2 Medtronic Business Overview and Its Total Revenue
13.4.3 Medtronic BioChips and BioMEMS Introduction
13.4.4 Medtronic Revenue in BioChips and BioMEMS Business (2015-2020)
13.4.5 Medtronic Recent Development and Reaction to COVID-19
13.5 Baxter International
13.5.1 Baxter International Company Details
13.5.2 Baxter International Business Overview and Its Total Revenue
13.5.3 Baxter International BioChips and BioMEMS Introduction
13.5.4 Baxter International Revenue in BioChips and BioMEMS Business (2015-2020)
13.5.5 Baxter International Recent Development and Reaction to COVID-19
13.6 Teledyne Dalsa
13.6.1 Teledyne Dalsa Company Details
13.6.2 Teledyne Dalsa Business Overview and Its Total Revenue
13.6.3 Teledyne Dalsa BioChips and BioMEMS Introduction
13.6.4 Teledyne Dalsa Revenue in BioChips and BioMEMS Business (2015-2020)
13.6.5 Teledyne Dalsa Recent Development and Reaction to COVID-19
13.7 Cepheid
13.7.1 Cepheid Company Details
13.7.2 Cepheid Business Overview and Its Total Revenue
13.7.3 Cepheid BioChips and BioMEMS Introduction
13.7.4 Cepheid Revenue in BioChips and BioMEMS Business (2015-2020)
13.7.5 Cepheid Recent Development and Reaction to COVID-19
13.8 Bluechiip
13.8.1 Bluechiip Company Details
13.8.2 Bluechiip Business Overview and Its Total Revenue
13.8.3 Bluechiip BioChips and BioMEMS Introduction
13.8.4 Bluechiip Revenue in BioChips and BioMEMS Business (2015-2020)
13.8.5 Bluechiip Recent Development and Reaction to COVID-19
13.9 Lepu Medical Technology
13.9.1 Lepu Medical Technology Company Details
13.9.2 Lepu Medical Technology Business Overview and Its Total Revenue
13.9.3 Lepu Medical Technology BioChips and BioMEMS Introduction
13.9.4 Lepu Medical Technology Revenue in BioChips and BioMEMS Business (2015-2020)
13.9.5 Lepu Medical Technology Recent Development and Reaction to COVID-19
13.10 Emulate
13.10.1 Emulate Company Details
13.10.2 Emulate Business Overview and Its Total Revenue
13.10.3 Emulate BioChips and BioMEMS Introduction
13.10.4 Emulate Revenue in BioChips and BioMEMS Business (2015-2020)
13.10.5 Emulate Recent Development and Reaction to COVID-19
13.11 TissUse
10.11.1 TissUse Company Details
10.11.2 TissUse Business Overview and Its Total Revenue
10.11.3 TissUse BioChips and BioMEMS Introduction
10.11.4 TissUse Revenue in BioChips and BioMEMS Business (2015-2020)
10.11.5 TissUse Recent Development and Reaction to COVID-19
13.12 Hesperos
10.12.1 Hesperos Company Details
10.12.2 Hesperos Business Overview and Its Total Revenue
10.12.3 Hesperos BioChips and BioMEMS Introduction
10.12.4 Hesperos Revenue in BioChips and BioMEMS Business (2015-2020)
10.12.5 Hesperos Recent Development and Reaction to COVID-19
13.13 CN Bio Innovations
10.13.1 CN Bio Innovations Company Details
10.13.2 CN Bio Innovations Business Overview and Its Total Revenue
10.13.3 CN Bio Innovations BioChips and BioMEMS Introduction
10.13.4 CN Bio Innovations Revenue in BioChips and BioMEMS Business (2015-2020)
10.13.5 CN Bio Innovations Recent Development and Reaction to COVID-19
13.14 Tara Biosystems
10.14.1 Tara Biosystems Company Details
10.14.2 Tara Biosystems Business Overview and Its Total Revenue
10.14.3 Tara Biosystems BioChips and BioMEMS Introduction
10.14.4 Tara Biosystems Revenue in BioChips and BioMEMS Business (2015-2020)
10.14.5 Tara Biosystems Recent Development and Reaction to COVID-19
13.15 Draper Laboratory
10.15.1 Draper Laboratory Company Details
10.15.2 Draper Laboratory Business Overview and Its Total Revenue
10.15.3 Draper Laboratory BioChips and BioMEMS Introduction
10.15.4 Draper Laboratory Revenue in BioChips and BioMEMS Business (2015-2020)
10.15.5 Draper Laboratory Recent Development and Reaction to COVID-19
13.16 Mimetas
10.16.1 Mimetas Company Details
10.16.2 Mimetas Business Overview and Its Total Revenue
10.16.3 Mimetas BioChips and BioMEMS Introduction
10.16.4 Mimetas Revenue in BioChips and BioMEMS Business (2015-2020)
10.16.5 Mimetas Recent Development and Reaction to COVID-19
13.17 Nortis
10.17.1 Nortis Company Details
10.17.2 Nortis Business Overview and Its Total Revenue
10.17.3 Nortis BioChips and BioMEMS Introduction
10.17.4 Nortis Revenue in BioChips and BioMEMS Business (2015-2020)
10.17.5 Nortis Recent Development and Reaction to COVID-19
13.18 Micronit Microtechnologies B.V.
10.18.1 Micronit Microtechnologies B.V. Company Details
10.18.2 Micronit Microtechnologies B.V. Business Overview and Its Total Revenue
10.18.3 Micronit Microtechnologies B.V. BioChips and BioMEMS Introduction
10.18.4 Micronit Microtechnologies B.V. Revenue in BioChips and BioMEMS Business (2015-2020)
10.18.5 Micronit Microtechnologies B.V. Recent Development and Reaction to COVID-19
13.19 Kirkstall
10.19.1 Kirkstall Company Details
10.19.2 Kirkstall Business Overview and Its Total Revenue
10.19.3 Kirkstall BioChips and BioMEMS Introduction
10.19.4 Kirkstall Revenue in BioChips and BioMEMS Business (2015-2020)
10.19.5 Kirkstall Recent Development and Reaction to COVID-19
13.20 Cherry Biotech SAS
10.20.1 Cherry Biotech SAS Company Details
10.20.2 Cherry Biotech SAS Business Overview and Its Total Revenue
10.20.3 Cherry Biotech SAS BioChips and BioMEMS Introduction
10.20.4 Cherry Biotech SAS Revenue in BioChips and BioMEMS Business (2015-2020)
10.20.5 Cherry Biotech SAS Recent Development and Reaction to COVID-19
13.21 Else Kooi Laboratory
10.21.1 Else Kooi Laboratory Company Details
10.21.2 Else Kooi Laboratory Business Overview and Its Total Revenue
10.21.3 Else Kooi Laboratory BioChips and BioMEMS Introduction
10.21.4 Else Kooi Laboratory Revenue in BioChips and BioMEMS Business (2015-2020)
10.21.5 Else Kooi Laboratory Recent Development and Reaction to COVID-19
14Analyst's Viewpoints/Conclusions
15Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables
    Table 1. BioChips and BioMEMS Key Market Segments
    Table 2. Key Players Covered: Ranking by BioChips and BioMEMS Revenue
    Table 3. Ranking of Global Top BioChips and BioMEMS Manufacturers by Revenue (US$ Million) in 2019
    Table 4. Global BioChips and BioMEMS Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
    Table 5. Key Players of DNA Chips
    Table 6. Key Players of Lab-on-a-chip
    Table 7. Key Players of Biosensors
    Table 8. Key Players of Drug Delivery Systems
    Table 9. Key Players of Microfluidic Devices
    Table 10. Key Players of Biomems Implants
    Table 11. Key Players of Silicon Structures
    Table 12. Key Players of Microactuators
    Table 13. COVID-19 Impact Global Market: (Four BioChips and BioMEMS Market Size Forecast Scenarios)
    Table 14. Opportunities and Trends for BioChips and BioMEMS Players in the COVID-19 Landscape
    Table 15. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
    Table 16. Key Regions/Countries Measures against Covid-19 Impact
    Table 17. Proposal for BioChips and BioMEMS Players to Combat Covid-19 Impact
    Table 18. Global BioChips and BioMEMS Market Size Growth by Application (US$ Million): 2020 VS 2026
    Table 19. Global BioChips and BioMEMS Market Size by Regions (US$ Million): 2020 VS 2026
    Table 20. Global BioChips and BioMEMS Market Size by Regions (2015-2020) (US$ Million)
    Table 21. Global BioChips and BioMEMS Market Share by Regions (2015-2020)
    Table 22. Global BioChips and BioMEMS Forecasted Market Size by Regions (2021-2026) (US$ Million)
    Table 23. Global BioChips and BioMEMS Market Share by Regions (2021-2026)
    Table 24. Market Top Trends
    Table 25. Key Drivers: Impact Analysis
    Table 26. Key Challenges
    Table 27. BioChips and BioMEMS Market Growth Strategy
    Table 28. Main Points Interviewed from Key BioChips and BioMEMS Players
    Table 29. Global BioChips and BioMEMS Revenue by Players (2015-2020) (Million US$)
    Table 30. Global BioChips and BioMEMS Market Share by Players (2015-2020)
    Table 31. Global Top BioChips and BioMEMS Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in BioChips and BioMEMS as of 2019)
    Table 32. Global BioChips and BioMEMS by Players Market Concentration Ratio (CR5 and HHI)
    Table 33. Key Players Headquarters and Area Served
    Table 34. Key Players BioChips and BioMEMS Product Solution and Service
    Table 35. Date of Enter into BioChips and BioMEMS Market
    Table 36. Mergers & Acquisitions, Expansion Plans
    Table 37. Global BioChips and BioMEMS Market Size by Type (2015-2020) (Million US$)
    Table 38. Global BioChips and BioMEMS Market Size Share by Type (2015-2020)
    Table 39. Global BioChips and BioMEMS Revenue Market Share by Type (2021-2026)
    Table 40. Global BioChips and BioMEMS Market Size Share by Application (2015-2020)
    Table 41. Global BioChips and BioMEMS Market Size by Application (2015-2020) (Million US$)
    Table 42. Global BioChips and BioMEMS Market Size Share by Application (2021-2026)
    Table 43. North America Key Players BioChips and BioMEMS Revenue (2019-2020) (Million US$)
    Table 44. North America Key Players BioChips and BioMEMS Market Share (2019-2020)
    Table 45. North America BioChips and BioMEMS Market Size by Type (2015-2020) (Million US$)
    Table 46. North America BioChips and BioMEMS Market Share by Type (2015-2020)
    Table 47. North America BioChips and BioMEMS Market Size by Application (2015-2020) (Million US$)
    Table 48. North America BioChips and BioMEMS Market Share by Application (2015-2020)
    Table 49. Europe Key Players BioChips and BioMEMS Revenue (2019-2020) (Million US$)
    Table 50. Europe Key Players BioChips and BioMEMS Market Share (2019-2020)
    Table 51. Europe BioChips and BioMEMS Market Size by Type (2015-2020) (Million US$)
    Table 52. Europe BioChips and BioMEMS Market Share by Type (2015-2020)
    Table 53. Europe BioChips and BioMEMS Market Size by Application (2015-2020) (Million US$)
    Table 54. Europe BioChips and BioMEMS Market Share by Application (2015-2020)
    Table 55. China Key Players BioChips and BioMEMS Revenue (2019-2020) (Million US$)
    Table 56. China Key Players BioChips and BioMEMS Market Share (2019-2020)
    Table 57. China BioChips and BioMEMS Market Size by Type (2015-2020) (Million US$)
    Table 58. China BioChips and BioMEMS Market Share by Type (2015-2020)
    Table 59. China BioChips and BioMEMS Market Size by Application (2015-2020) (Million US$)
    Table 60. China BioChips and BioMEMS Market Share by Application (2015-2020)
    Table 61. Japan Key Players BioChips and BioMEMS Revenue (2019-2020) (Million US$)
    Table 62. Japan Key Players BioChips and BioMEMS Market Share (2019-2020)
    Table 63. Japan BioChips and BioMEMS Market Size by Type (2015-2020) (Million US$)
    Table 64. Japan BioChips and BioMEMS Market Share by Type (2015-2020)
    Table 65. Japan BioChips and BioMEMS Market Size by Application (2015-2020) (Million US$)
    Table 66. Japan BioChips and BioMEMS Market Share by Application (2015-2020)
    Table 67. Southeast Asia Key Players BioChips and BioMEMS Revenue (2019-2020) (Million US$)
    Table 68. Southeast Asia Key Players BioChips and BioMEMS Market Share (2019-2020)
    Table 69. Southeast Asia BioChips and BioMEMS Market Size by Type (2015-2020) (Million US$)
    Table 70. Southeast Asia BioChips and BioMEMS Market Share by Type (2015-2020)
    Table 71. Southeast Asia BioChips and BioMEMS Market Size by Application (2015-2020) (Million US$)
    Table 72. Southeast Asia BioChips and BioMEMS Market Share by Application (2015-2020)
    Table 73. India Key Players BioChips and BioMEMS Revenue (2019-2020) (Million US$)
    Table 74. India Key Players BioChips and BioMEMS Market Share (2019-2020)
    Table 75. India BioChips and BioMEMS Market Size by Type (2015-2020) (Million US$)
    Table 76. India BioChips and BioMEMS Market Share by Type (2015-2020)
    Table 77. India BioChips and BioMEMS Market Size by Application (2015-2020) (Million US$)
    Table 78. India BioChips and BioMEMS Market Share by Application (2015-2020)
    Table 79. Central & South America Key Players BioChips and BioMEMS Revenue (2019-2020) (Million US$)
    Table 80. Central & South America Key Players BioChips and BioMEMS Market Share (2019-2020)
    Table 81. Central & South America BioChips and BioMEMS Market Size by Type (2015-2020) (Million US$)
    Table 82. Central & South America BioChips and BioMEMS Market Share by Type (2015-2020)
    Table 83. Central & South America BioChips and BioMEMS Market Size by Application (2015-2020) (Million US$)
    Table 84. Central & South America BioChips and BioMEMS Market Share by Application (2015-2020)
    Table 85. Abbott Laboratories Company Details
    Table 86. Abbott Laboratories Business Overview
    Table 87. Abbott Laboratories Product
    Table 88. Abbott Laboratories Revenue in BioChips and BioMEMS Business (2015-2020) (Million US$)
    Table 89. Abbott Laboratories Recent Development
    Table 90. Boston Scientific Company Details
    Table 91. Boston Scientific Business Overview
    Table 92. Boston Scientific Product
    Table 93. Boston Scientific Revenue in BioChips and BioMEMS Business (2015-2020) (Million US$)
    Table 94. Boston Scientific Recent Development
    Table 95. Perkin Elmer Company Details
    Table 96. Perkin Elmer Business Overview
    Table 97. Perkin Elmer Product
    Table 98. Perkin Elmer Revenue in BioChips and BioMEMS Business (2015-2020) (Million US$)
    Table 99. Perkin Elmer Recent Development
    Table 100. Medtronic Company Details
    Table 101. Medtronic Business Overview
    Table 102. Medtronic Product
    Table 103. Medtronic Revenue in BioChips and BioMEMS Business (2015-2020) (Million US$)
    Table 104. Medtronic Recent Development
    Table 105. Baxter International Company Details
    Table 106. Baxter International Business Overview
    Table 107. Baxter International Product
    Table 108. Baxter International Revenue in BioChips and BioMEMS Business (2015-2020) (Million US$)
    Table 109. Baxter International Recent Development
    Table 110. Teledyne Dalsa Company Details
    Table 111. Teledyne Dalsa Business Overview
    Table 112. Teledyne Dalsa Product
    Table 113. Teledyne Dalsa Revenue in BioChips and BioMEMS Business (2015-2020) (Million US$)
    Table 114. Teledyne Dalsa Recent Development
    Table 115. Cepheid Company Details
    Table 116. Cepheid Business Overview
    Table 117. Cepheid Product
    Table 118. Cepheid Revenue in BioChips and BioMEMS Business (2015-2020) (Million US$)
    Table 119. Cepheid Recent Development
    Table 120. Bluechiip Business Overview
    Table 121. Bluechiip Product
    Table 122. Bluechiip Company Details
    Table 123. Bluechiip Revenue in BioChips and BioMEMS Business (2015-2020) (Million US$)
    Table 124. Bluechiip Recent Development
    Table 125. Lepu Medical Technology Company Details
    Table 126. Lepu Medical Technology Business Overview
    Table 127. Lepu Medical Technology Product
    Table 128. Lepu Medical Technology Revenue in BioChips and BioMEMS Business (2015-2020) (Million US$)
    Table 129. Lepu Medical Technology Recent Development
    Table 130. Emulate Company Details
    Table 131. Emulate Business Overview
    Table 132. Emulate Product
    Table 133. Emulate Revenue in BioChips and BioMEMS Business (2015-2020) (Million US$)
    Table 134. Emulate Recent Development
    Table 135. TissUse Company Details
    Table 136. TissUse Business Overview
    Table 137. TissUse Product
    Table 138. TissUse Revenue in BioChips and BioMEMS Business (2015-2020) (Million US$)
    Table 139. TissUse Recent Development
    Table 140. Hesperos Company Details
    Table 141. Hesperos Business Overview
    Table 142. Hesperos Product
    Table 143. Hesperos Revenue in BioChips and BioMEMS Business (2015-2020) (Million US$)
    Table 144. Hesperos Recent Development
    Table 145. CN Bio Innovations Company Details
    Table 146. CN Bio Innovations Business Overview
    Table 147. CN Bio Innovations Product
    Table 148. CN Bio Innovations Revenue in BioChips and BioMEMS Business (2015-2020) (Million US$)
    Table 149. CN Bio Innovations Recent Development
    Table 150. Tara Biosystems Company Details
    Table 151. Tara Biosystems Business Overview
    Table 152. Tara Biosystems Product
    Table 153. Tara Biosystems Revenue in BioChips and BioMEMS Business (2015-2020) (Million US$)
    Table 154. Tara Biosystems Recent Development
    Table 155. Draper Laboratory Company Details
    Table 156. Draper Laboratory Business Overview
    Table 157. Draper Laboratory Product
    Table 158. Draper Laboratory Revenue in BioChips and BioMEMS Business (2015-2020) (Million US$)
    Table 159. Draper Laboratory Recent Development
    Table 160. Mimetas Company Details
    Table 161. Mimetas Business Overview
    Table 162. Mimetas Product
    Table 163. Mimetas Revenue in BioChips and BioMEMS Business (2015-2020) (Million US$)
    Table 164. Mimetas Recent Development
    Table 165. Nortis Company Details
    Table 166. Nortis Business Overview
    Table 167. Nortis Product
    Table 168. Nortis Revenue in BioChips and BioMEMS Business (2015-2020) (Million US$)
    Table 169. Nortis Recent Development
    Table 170. Micronit Microtechnologies B.V. Company Details
    Table 171. Micronit Microtechnologies B.V. Business Overview
    Table 172. Micronit Microtechnologies B.V. Product
    Table 173. Micronit Microtechnologies B.V. Revenue in BioChips and BioMEMS Business (2015-2020) (Million US$)
    Table 174. Micronit Microtechnologies B.V. Recent Development
    Table 175. Kirkstall Company Details
    Table 176. Kirkstall Business Overview
    Table 177. Kirkstall Product
    Table 178. Kirkstall Revenue in BioChips and BioMEMS Business (2015-2020) (Million US$)
    Table 179. Kirkstall Recent Development
    Table 180. Cherry Biotech SAS Company Details
    Table 181. Cherry Biotech SAS Business Overview
    Table 182. Cherry Biotech SAS Product
    Table 183. Cherry Biotech SAS Revenue in BioChips and BioMEMS Business (2015-2020) (Million US$)
    Table 184. Cherry Biotech SAS Recent Development
    Table 185. Else Kooi Laboratory Company Details
    Table 186. Else Kooi Laboratory Business Overview
    Table 187. Else Kooi Laboratory Product
    Table 188. Else Kooi Laboratory Revenue in BioChips and BioMEMS Business (2015-2020) (Million US$)
    Table 189. Else Kooi Laboratory Recent Development
    Table 190. Research Programs/Design for This Report
    Table 191. Key Data Information from Secondary Sources
    Table 192. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global BioChips and BioMEMS Market Share by Type: 2020 VS 2026
    Figure 2. DNA Chips Features
    Figure 3. Lab-on-a-chip Features
    Figure 4. Biosensors Features
    Figure 5. Drug Delivery Systems Features
    Figure 6. Microfluidic Devices Features
    Figure 7. Biomems Implants Features
    Figure 8. Silicon Structures Features
    Figure 9. Microactuators Features
    Figure 10. Global BioChips and BioMEMS Market Share by Application: 2020 VS 2026
    Figure 11. Hospital Case Studies
    Figure 12. Labrary Case Studies
    Figure 13. Other Case Studies
    Figure 14. BioChips and BioMEMS Report Years Considered
    Figure 15. Global BioChips and BioMEMS Market Size YoY Growth 2015-2026 (US$ Million)
    Figure 16. Global BioChips and BioMEMS Market Share by Regions: 2020 VS 2026
    Figure 17. Global BioChips and BioMEMS Market Share by Regions (2021-2026)
    Figure 18. Porter's Five Forces Analysis
    Figure 19. Global BioChips and BioMEMS Market Share by Players in 2019
    Figure 20. Global Top BioChips and BioMEMS Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in BioChips and BioMEMS as of 2019
    Figure 21. The Top 10 and 5 Players Market Share by BioChips and BioMEMS Revenue in 2019
    Figure 22. North America BioChips and BioMEMS Market Size YoY Growth (2015-2020) (Million US$)
    Figure 23. Europe BioChips and BioMEMS Market Size YoY Growth (2015-2020) (Million US$)
    Figure 24. China BioChips and BioMEMS Market Size YoY Growth (2015-2020) (Million US$)
    Figure 25. Japan BioChips and BioMEMS Market Size YoY Growth (2015-2020) (Million US$)
    Figure 26. Southeast Asia BioChips and BioMEMS Market Size YoY Growth (2015-2020) (Million US$)
    Figure 27. India BioChips and BioMEMS Market Size YoY Growth (2015-2020) (Million US$)
    Figure 28. Central & South America BioChips and BioMEMS Market Size YoY Growth (2015-2020) (Million US$)
    Figure 29. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 30. Abbott Laboratories Revenue Growth Rate in BioChips and BioMEMS Business (2015-2020)
    Figure 31. Boston Scientific Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 32. Boston Scientific Revenue Growth Rate in BioChips and BioMEMS Business (2015-2020)
    Figure 33. Perkin Elmer Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 34. Perkin Elmer Revenue Growth Rate in BioChips and BioMEMS Business (2015-2020)
    Figure 35. Medtronic Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 36. Medtronic Revenue Growth Rate in BioChips and BioMEMS Business (2015-2020)
    Figure 37. Baxter International Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 38. Baxter International Revenue Growth Rate in BioChips and BioMEMS Business (2015-2020)
    Figure 39. Teledyne Dalsa Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 40. Teledyne Dalsa Revenue Growth Rate in BioChips and BioMEMS Business (2015-2020)
    Figure 41. Cepheid Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 42. Cepheid Revenue Growth Rate in BioChips and BioMEMS Business (2015-2020)
    Figure 43. Bluechiip Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 44. Bluechiip Revenue Growth Rate in BioChips and BioMEMS Business (2015-2020)
    Figure 45. Lepu Medical Technology Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 46. Lepu Medical Technology Revenue Growth Rate in BioChips and BioMEMS Business (2015-2020)
    Figure 47. Emulate Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 48. Emulate Revenue Growth Rate in BioChips and BioMEMS Business (2015-2020)
    Figure 49. TissUse Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 50. TissUse Revenue Growth Rate in BioChips and BioMEMS Business (2015-2020)
    Figure 51. Hesperos Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 52. Hesperos Revenue Growth Rate in BioChips and BioMEMS Business (2015-2020)
    Figure 53. CN Bio Innovations Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 54. CN Bio Innovations Revenue Growth Rate in BioChips and BioMEMS Business (2015-2020)
    Figure 55. Tara Biosystems Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 56. Tara Biosystems Revenue Growth Rate in BioChips and BioMEMS Business (2015-2020)
    Figure 57. Draper Laboratory Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 58. Draper Laboratory Revenue Growth Rate in BioChips and BioMEMS Business (2015-2020)
    Figure 59. Mimetas Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 60. Mimetas Revenue Growth Rate in BioChips and BioMEMS Business (2015-2020)
    Figure 61. Nortis Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 62. Nortis Revenue Growth Rate in BioChips and BioMEMS Business (2015-2020)
    Figure 63. Micronit Microtechnologies B.V. Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 64. Micronit Microtechnologies B.V. Revenue Growth Rate in BioChips and BioMEMS Business (2015-2020)
    Figure 65. Kirkstall Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 66. Kirkstall Revenue Growth Rate in BioChips and BioMEMS Business (2015-2020)
    Figure 67. Cherry Biotech SAS Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 68. Cherry Biotech SAS Revenue Growth Rate in BioChips and BioMEMS Business (2015-2020)
    Figure 69. Bottom-up and Top-down Approaches for This Report
    Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3900

This license allows only one user(purchaser of the report) to access the PDF.
Electronic (PDF)

$5850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Nano Dimension

RELATED REPORTS

Global Microcarrier Bioreactor Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-4O8609
Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global Immunohistochemistry Reagent Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-25I8231
Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global RNA Analysis & Transcriptomic Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-2M4266
Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global PCR Tubes And PCR Plates Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-38E8328
Wed Apr 17 00:00:00 UTC 2024

Add to Cart